From FDA approvals to new studies, here are four updates on two-level disc replacement to know, as reported by Becker’s since May 29:
- Centinel Spine received FDA premarket approval Oct. 14 for two-level use of its prodisc C Vivo and prodisc C SK cervical disc replacement devices.
- A 93-year-old woman underwent a successful 2-level lumbar decompression with spinal anesthesia.
- Aclarion enrolled its first patients in a clinical trial designed to reduce back pain at the Texas Back Institute in Plano.
- Hybrid anterior cervical discectomy and fusion and cervical disc replacement is a growing option for multilevel cervical disc degenerative disease, and early fusion rates are stronger, according to a study in the June 2025 issue of The Spine Journal.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
